We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Michael Kahaleh

Michael Kahaleh MD, AGAF, FACG, FASGE

Chief of Endoscopy, Weill Cornell Medical College, New York, New York

Michel Kahaleh, MD, AGAF, FACG, FASGE is the Chief of Endoscopy at Weill Cornell Medical College. Trained in Erasme Hospital, University of Brussels, he led the Pancreatico-Biliary team of endoscopists at the University of Virginia before joining Well Cornell Medical College in July 2011. He is a world renowned endoscopist boarded in both Europe and the United States. He is fluent is French, Spanish and Arabic.

The adjunct use of both Endoscopic Retrograde Cholangiopancreatography (ERCP) and Endoscopic Ultrasonography (EUS) has permitted him and his team to successfully treat pancreatic collections and perform newly described procedures that have had a major impact on patient management.

With over 100 publications, Dr. Kahaleh's research has primarily focused on interventional endoscopy. He continually serves as a primary investigator on many clinical trials; including those that involve the use of new devices to diagnose and treat biliary and pancreatic diseases. A major focus of his research is on preventing and treating complications of advanced endoscopic procedures. He is actively analyzing the efficacy of metallic stents in both benign and malignant diseases. Another area of investigation for Dr. Kahaleh is understanding and preventing biliary and pancreatic cancer. The objective is to develop new diagnostic techniques for reducing the mortality associated with those cancers, by detecting them earlier and treating them using novel therapies such as laser therapy, photodynamic therapy and radiofrequency ablation. He is now developing endoscopic surgery and has incorporated in his unit Endoscopic Submucosal Dissection (ESD), Peroral Endoscopic Myotomy (POEM) and Endoscopic suturing.